September 1, 2017

Source: BIO

This year’s BIO 2017 International Convention drew over 16,000 biotechnology industry leaders and policymakers from 48 states and 73 countries to San Diego. As the world’s largest biotechnology event, BIO 2017 provided attendees with unique perspectives on the immense opportunities and complex challenges ahead for the industry.

CIAPM researchers discussed their scientific advances in areas such as:

• Improving the early treatment of prostate cancer through assessment of patient characteristics, cancer severity indicators and genomics.
• Helping patients better manage chronic conditions such as high blood pressure and depression by gathering personal health data through their mobile phones.
• Speeding up diagnosis of traumatic brain injury, stroke or aneurysm by applying state-of-the-art artificial intelligence technology to computed tomography (CT) scanning.
• Creating a catalogue of DNA variants to better identify the causes of disease in children that suffer from difficult to diagnose conditions.
• Combining clinical and real-time patient data in an interactive tool that patients with multiple sclerosis (MS) and their doctors can use to improve outcomes.
• More quickly identifying early signs of a cardiovascular disease by providing patients with specialized watches that transmit health data to their doctors.
• Using state-of-the-art genomic analyses to better diagnose children with cancer and critically ill patients with infectious disease.